On February 1, the AIDS Clinical Trial Group (ACTG) Network at the National Institute for Allergy and Infectious Diseases/National Institutes for Health named numerous staff of the Baltimore-Washington-India Clinical Trials Unit to 2016 committee positions. BWI-CTU Co-principal Investigator Dr. Amita Gupta noted that “BWI-CTU clinical site operations have yielded important discoveries in preventing and treating HIV for decades, and CTU staff are highly regarded internationally as experts in the field. We are enormously proud to have the team’s dedicated researchers and regulatory officials recognized for their knowledge and commitment to HIV prevention and treatment globally. ”

 

Congratulations go to:

 

Charles W. Flexner, MD, Site Leader 

• Protocol Pharmacologist for ACTG 5258 and ACTG 5336

 

Amita Gupta, MD, Site Investigator

• Chair, IMPAACT P1078
• Co-chair ACTG 5274
• Vice-chair ACTG 5279
• Co-chair ACTG 5300/IMPAACT 2005 Phoenix preparation study and main trial
• Vice-chair, IMPAACT TB Scientific Committee
• Investigator, Tuberculosis Transformative Science Group
• Member, Clinical Management Committee, IMPAACT PROMISE P1077
• Co-Investigator IMPAACT P1026s and IMPAACT P2001
• Member, Women’s Health Inter-Network Scientific Committee

 

Allison Agwu, MD, Site Investigator

• Past Co-chair, Complications Scientific Committee
• Member Complications Scientific Committee
• Co-investigator/protocol team member, Maternal and Infant Monitoring for Evidence of Toxicity Related to Tenofovir Exposure: The Bone and Kidney Health Substudy of IMPAACT P1077 PROMISE: Promoting Maternal and Infant Survival Everywhere
• IMPAACT Representative, WHISC Committee
• Co-investigator, Biomarkers of Neurodevelopmental and Mental Health Outcomes in Perinatally HIV-Infected or Exposed Children and Adolescents

 

Adriana Andrade, MD, Site Investigator

• Co-chair, ACTG 5350
• Chair, ACTG 5248
• Protocol Pharmacologist, ACTG 5241
• Member, Neurology and ARTs Committees
• Member, Clinical Pharmacology Advisory Group
• Member, Monoclonal Antibodies Working Group, Adherence Working Group, and Microbiome Focus Group
• Investigator, End-Organ Disease/Inflammation Transformative Science Group (Dec 2015-17)
• Investigator, Antiretroviral Therapy Strategies Subcommittee (Dec 2015-17)

 

Ashwin Balagopal, MD

• Chair, ACTG 5335s
• Investigator ACTG 5329 and ACTG 5334s
• Investigator, Hepatitis Transformative Science Group, (Feb 2016-Nov 2017)

 

Todd T. Brown, MD, Site Investigator

• Member, Inflammation TSG
• Protocol Co-Chair, ACTG 5260s, ACTG 5318 (LEACH)
• Protocol Vice-Chair, ACTG 5280, ACTG 5303
• Co-investigator, ACTG 5257

 

Richard Chaisson, MD, Site Investigator

• Chair, ACTG Tuberculosis TSG
• Member, Scientific Agenda Steering Committee (SASC)
• Chair ACTG 5279
• Co-chair ACTG 5344
• Protocol Team Member ACTG 5300, ACTG 5312, ACTG 5349

 

Kelly Dooley, MD, Site Investigator

• Member, ACTG Tuberculosis TSG and IMPAACT TB Scientific Committee
• Protocol chair, IMPAACT P2005
• Protocol co-chair, ACTG 5343, ACTG 5312
• Protocol vice chair IMPAACT 2001
• Protocol Team Member ACTG 5338, ACTG 5300, IMPAACT 1108
• Pharmacologist, Tuberculosis Transformative Science Group (Dec 2015-17)

 

Christine Durand, MD, Site Investigator

• Member, HIV Reservoirs and Viral Eradication Transformative Science Group
• Vice-chair, ACTG 5342

 

Jason Farley, PHD, Site Investigator

• HPTN Site Leader; Investigator of Record HPTN 069
• Protocol team co-investigator HPTN 078
• Investigator of Record HPTN 078

 

Nikhil Gupte, PhD, Site Investigator

• Member, Training and Education Subcomittee

 

Savita Kanade, MSc

• ACTG Outreach and Retention Committee Chair

 

Vandana Kulkarni, MS, Site Laboratory Manager

• Member TB Lab Core Team
• Protocol Technologist for IMPAACT 1078, ACTG 5297, ACTG 5288,
• ACTG 5318, ACTG 5338
• Voting member, Laboratory Technologists Committee

 

Vidya Mave, MD, BJMC Site Leader

• Member, Co-Infections and Malignancies Subcommittee
• Co-Investigator in IMPAACT 2001, IMPAACT 1073, ACTG 5302
• Member, Tuberculosis Transformative Science Group (2014-Nov2016)
• Member, End-Organ Disease and Inflammation Transformative Science Group (Feb 2016-Nov 2017)

 

Smita Nimkar, MS, BJMC Site Regulatory Coordinator

• Co-vice chair, Site Management and Clinical Care Committee (SMCCC) (Feb 2016-Nov 2017)

 

Eric Nuermberger, Investigator

• Investigator, TB Transformative Science Group

 

Sandesh Patil MD, BJMC OB/GYN Clinical Research Officer

• Vice chair, IMPAACT P2001

 

Estelle Piwowar-Manning, M.T., Assistant Director HPTN Central Laboratory

Malaria Diagnostics Working Group of the Lab Steering Committee

 

Neeta Pradhan, MSc, BJMC Site Laboratory Technologist

TB Lab Core Team Mentoring Group      
Non-Voting Member, Lab Technologist Committee

 

Vivian Rexroad, PharmD, Pharmacy Services Manager

Network Pharmacist, IMPAACT Leadership
Member, IMPAACT Multidisciplinary Protocol Review Group
Protocol team member for IMPAACT 1078, IMPAACT 1114 and IMPAACT 2000
General Member (Pharmacist), Protocol Development and Implementation Subcommittee of the SMCCC (Feb 2016-Nov2017)

 

Ned Sacktor, MD, Site Investigator

• Member, Neurology Working Group
• Protocol Chair, ACTG 5235

 

Sunil Solomon, MD, Site Investigator

• Investigator-at-Large, Hepatitis TSG
• Investigator, Hepatitis Transformative Science Group (Dec 2015-17)

 

Mark Sulkowski, MD, Site Investigator

• Vice-chair, Hepatitis TSG
• Chair ACTG 5329

 

Nishi Suryavanshi, PhD, BJMC Site Coordinator

Member, Site Operations Subcommittee
International Coordinator, Intensity Scoring Panel Working Group for the Performance Evaluation
Member, Cross-Network Site Coordinators Working Group

 

Andrea B. Weiss, RP, Site Pharmacist

• Member, ACTG Pharmacy Subcommittee

 

Ilene Wiggins, RN, Research Manager

• Ex-Officio chair, Site Operations Subcommittee
• Vice Chair, Site Management and Clinical Care Committee
• Chair, Intensity Scoring Panel Working Group for the Performance Evaluation Committee